Allianz Asset Management Gmb H Vertex Pharmaceuticals Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 258,885 shares of VRTX stock, worth $120 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

258,885

Previous 334,594 22.63%

Holding current value

$120 Million

Previous $157 Million 23.23%

% of portfolio

0.17%

Previous 0.24%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $34.8 Million - $38.3 Million	-75,709 Reduced 22.63%	258,885 $120 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $19.4 Million - $24 Million	-49,484 Reduced 12.88%	334,594 $157 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $14.6 Million - $15.9 Million	-35,709 Reduced 8.51%	384,078 $161 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $20.2 Million - $24.2 Million	-58,972 Reduced 12.32%	419,787 $171 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $5.6 Million - $6.01 Million	-16,571 Reduced 3.35%	478,759 $166 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $91.7 Million - $103 Million	-291,644 Reduced 37.06%	495,330 $174 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $4.33 Million - $4.94 Million	-15,296 Reduced 1.91%	786,974 $248 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $22.4 Million - $25.2 Million	-78,484 Reduced 8.91%	802,270 $232 Million
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $87.9 Million - $98.1 Million	-321,150 Reduced 26.72%	880,754 $255 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $124 Million - $155 Million	529,249 Added 78.68%	1,201,904 $339 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $2.62 Million - $3.09 Million	11,828 Added 1.79%	672,655 $176 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $1.53 Million - $1.93 Million	-8,617 Reduced 1.29%	660,827 $145 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $27.9 Million - $31.2 Million	153,686 Added 29.8%	669,444 $121 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $19.8 Million - $23.3 Million	105,558 Added 25.73%	515,758 $104 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $356,074 - $415,053	1,720 Added 0.42%	410,200 $88.1 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $79.3 Million - $106 Million	-383,244 Reduced 48.41%	408,480 $96.5 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $14.4 Million - $17.1 Million	-56,384 Reduced 6.65%	791,724 $215 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $8.87 Million - $11.6 Million	39,339 Added 4.86%	848,108 $246 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $31.1 Million - $38.6 Million	-155,600 Reduced 16.13%	808,769 $192 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $82.7 Million - $111 Million	-495,910 Reduced 33.96%	964,369 $211 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $17.3 Million - $19.4 Million	-103,877 Reduced 6.64%	1,460,279 $247 Million
Q2 2019 Aug 08, 2019	BUY	$164.61 - $190.37 $15,144 - $17,514	92 Added 0.01%	1,564,156 $287 Million
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $26.5 Million - $31.6 Million	-162,083 Reduced 9.39%	1,564,064 $288 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $5.45 Million - $6.89 Million	-35,845 Reduced 2.03%	1,726,147 $286 Million
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $29.5 Million - $33.9 Million	175,700 Added 11.08%	1,761,992 $340 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $28.2 Million - $32.9 Million	193,487 Added 13.89%	1,586,292 $270 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $97.7 Million - $114 Million	644,218 Added 86.06%	1,392,805 $227 Million
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $3.71 Million - $4.2 Million	27,001 Added 3.74%	748,587 $112 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $70.4 Million - $77.1 Million	475,427 Added 193.14%	721,586 $110 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-84,109 Reduced 25.47%	246,159 $31.4 Million
Q1 2017 Apr 17, 2019	SELL	N/A	-203,642 Reduced 38.14%	330,268 $35.9 Million
Q4 2016 Apr 17, 2019	BUY	N/A	184,452 Added 52.78%	533,910 $39.3 Million
Q3 2016 Apr 17, 2019	BUY	N/A	349,458	349,458 $30 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Vertex Pharmaceuticals Inc Transaction History